Enveda Biosciences Launches Clinical Trials for IBD Drug Candidate
Boulder-based Enveda Biosciences has received clearance from the U.S. Food and Drug Administration (FDA) to initiate clinical trials for its drug candidate, ENV-6946, aimed at treating inflammatory bowel disease (IBD).…